{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:00:50Z","timestamp":1791568850401,"version":"4.3.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,25]]},"DOI":"10.7759\/cureus.65390","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T03:25:12Z","timestamp":1721964312000},"source":"Crossref","is-referenced-by-count":6,"title":["Sodium Valproate-Induced Hyperammonemia: A Case Series in a Tertiary Care Hospital"],"prefix":"10.7759","author":[{"given":"Pallavi","family":"Abhilasha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh K","family":"Badyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/NJPT.NJPT_39_23","article-title":"Paracetamol induced facial puffiness: an uncommon case report","volume":"1","author":"Siddhu CK","year":"2023","unstructured":"Siddhu CK, Joseph G, Bhatti N, Badyal D. Paracetamol induced facial puffiness: an uncommon case report. Nat J Pharm Therap. 2023, 1:170-2. 10.4103\/NJPT.NJPT_39_23","journal-title":"Nat J Pharm Therap"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-4651-7","article-title":"Adverse drug reactions in primary care: a scoping review","volume":"20","author":"Khalil H","year":"2020","unstructured":"Khalil H, Huang C. Adverse drug reactions in primary care: a scoping review. BMC Health Serv Res. 2020, 20:5. 10.1186\/s12913-019-4651-7","journal-title":"BMC Health Serv Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1104251","article-title":"Sodium valproate-induced nocturnal enuresis in epilepsy: Three case reports and a review of the literature","volume":"14","author":"Zhang X","year":"2023","unstructured":"Zhang X, Lu W, Mo X. Sodium valproate-induced nocturnal enuresis in epilepsy: Three case reports and a review of the literature. Front Neurol. 2023, 14:1104251. 10.3389\/fneur.2023.1104251","journal-title":"Front Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.645518","article-title":"Sodium valproate-induced chromatin remodeling","volume":"9","author":"Mello ML","year":"2021","unstructured":"Mello ML. Sodium valproate-induced chromatin remodeling. Front Cell Dev Biol. 2021, 9:645518. 10.3389\/fcell.2021.645518","journal-title":"Front Cell Dev Biol"},{"key":"ref5","article-title":"Valproic acid","author":"Rahman M","year":"2024","unstructured":"Rahman M, Awosika AO, Nguyen H. Valproic acid. StatPearls Publishing, Treasure Island, USA; 2024."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1593","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"9","author":"Farooq F","year":"2017","unstructured":"Farooq F, Sahib Din J, Khan AM, Naqvi S, Shagufta S, Mohit A. Valproate-induced hyperammonemic encephalopathy. Cureus. 2017, 9:e1593. 10.7759\/cureus.1593","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-020-2343-x","article-title":"Valproate-induced hyperammonemic encephalopathy: a case report","volume":"14","author":"Shah S","year":"2020","unstructured":"Shah S, Wang R, Vieux U. Valproate-induced hyperammonemic encephalopathy: a case report. J Med Case Rep. 2020, 14:19. 10.1186\/s13256-020-2343-x","journal-title":"J Med Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2021.021","article-title":"Impact of non-hepatic hyperammonemia on mortality in intensive care unit patients: a retrospective cohort study","volume":"36","author":"Kim JH","year":"2021","unstructured":"Kim JH, Jeon H, Lee SS, et al.. Impact of non-hepatic hyperammonemia on mortality in intensive care unit patients: a retrospective cohort study. Korean J Intern Med. 2021, 36:1347-55. 10.3904\/kjim.2021.021","journal-title":"Korean J Intern Med"},{"key":"ref9","unstructured":"VigiAccess. (2015). Accessed. March 28, 2024: https:\/\/www.vigiaccess.org\/."},{"key":"ref10","article-title":"LiverTox: clinical and research information on drug-induced liver injury","year":"2019","unstructured":"LiverTox. clinical and research information on drug-induced liver injury.  National Institute of  Diabetes and Digestive and Kidney Diseases, Bethesda, USA; 2019."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06289-0","article-title":"Valproic acid-induced hyperammonemia in neuropsychiatric disorders: a 2-year clinical survey","volume":"240","author":"Hosseini H","year":"2023","unstructured":"Hosseini H, Shafie M, Shakiba A, Ghayyem H, Mayeli M, Hassani M, Aghamollaii V. Valproic acid-induced hyperammonemia in neuropsychiatric disorders: a 2-year clinical survey. Psychopharmacol (Berl). 2023, 240:149-56. 10.1007\/s00213-022-06289-0","journal-title":"Psychopharmacol (Berl)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.11138\/gchir\/2015.36.4.158","article-title":"Valproic acid-induced acute pancreatitis in pediatric age: case series and review of literature","volume":"36","author":"Cofini M","year":"2015","unstructured":"Cofini M, Quadrozzi F, Favoriti P, Favoriti M, Cofini G. Valproic acid-induced acute pancreatitis in pediatric age: case series and review of literature. G Chir. 2015, 36:158-60. 10.11138\/gchir\/2015.36.4.158","journal-title":"G Chir"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jmd2.12131","article-title":"Use of carglumic acid in valproate-induced hyperammonemia: 25 pediatric cases","volume":"55","author":"Palomino P\u00e9rez LM","year":"2020","unstructured":"Palomino P\u00e9rez LM, Mart\u00edn-Rivada \u00c1, Ca\u00f1edo Villaroya E, Garc\u00eda-Pe\u00f1as JJ, Cuervas-Mons Vendrell M, Pedr\u00f3n-Giner C. Use of carglumic acid in valproate-induced hyperammonemia: 25 pediatric cases. JIMD Rep. 2020, 55:3-11. 10.1002\/jmd2.12131","journal-title":"JIMD Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2021.07.243","article-title":"Hyperammonemia in patients receiving valproic acid in the hospital setting: a retrospective review","volume":"11","author":"McMorris T","year":"2021","unstructured":"McMorris T, Chu A, Vu L, Bernardini A. Hyperammonemia in patients receiving valproic acid in the hospital setting: a retrospective review. Ment Health Clin. 2021, 11:243-7. 10.9740\/mhc.2021.07.243","journal-title":"Ment Health Clin"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000066","article-title":"Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy","volume":"93","author":"Tseng YL","year":"2014","unstructured":"Tseng YL, Huang CR, Lin CH, et al.. Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy. Medicine (Baltimore). 2014, 93:e66. 10.1097\/MD.0000000000000066","journal-title":"Medicine (Baltimore)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2019.12.005","article-title":"Characteristics and outcomes of critically ill patients with severe hyperammonemia","volume":"56","author":"Jacoby KJ","year":"2020","unstructured":"Jacoby KJ, Singh P, Prekker ME, Leatherman JW. Characteristics and outcomes of critically ill patients with severe hyperammonemia. J Crit Care. 2020, 56:177-81. 10.1016\/j.jcrc.2019.12.005","journal-title":"J Crit Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.55519\/JAMC-04-S4-10190","article-title":"Valproate induced hyperammonemic encephalopathy","volume":"34","author":"Qayyum W","year":"2022","unstructured":"Qayyum W, Yousafzai ZA, Iqbal MS, Khan S, Amin QK, Shafiqs I. Valproate induced hyperammonemic encephalopathy. J Ayub Med Coll Abbottabad. 2022, 34:S1038-9. 10.55519\/JAMC-04-S4-10190","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.694362","article-title":"Valproate-induced hyperammonemic encephalopathy: a brief review","volume":"28","author":"Lewis C","year":"2012","unstructured":"Lewis C, Deshpande A, Tesar GE, Dale R. Valproate-induced hyperammonemic encephalopathy: a brief review. Curr Med Res Opin. 2012, 28:1039-42. 10.1185\/03007995.2012.694362","journal-title":"Curr Med Res Opin"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.18-5-430","article-title":"Lesson of the month 1: Sodium valproate-induced encephalopathy","volume":"18","author":"Camilleri L","year":"2018","unstructured":"Camilleri L. Lesson of the month 1: Sodium valproate-induced encephalopathy. Clin Med (Lond). 2018, 18:430-2. 10.7861\/clinmedicine.18-5-430","journal-title":"Clin Med (Lond)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/274385-sodium-valproate-induced-hyperammonemia-a-case-series-in-a-tertiary-care-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T03:25:18Z","timestamp":1721964318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/274385-sodium-valproate-induced-hyperammonemia-a-case-series-in-a-tertiary-care-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.65390","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,25]]}}}